Results 21 to 30 of about 34,498 (300)

"Testicular Torsion in a Child With CPT-1 Deficiency and History of Viral Myositis: Anesthesia Considerations". [PDF]

open access: yesClin Case Rep
ABSTRACT Tailored anesthetic management is crucial for pediatric patients with inborn metabolic disorders like CPT‐1 deficiency and conditions, such as viral myositis. Avoiding inhalational anesthetics and succinylcholine, using glucose infusion, safe anesthetics, and appropriate monitoring are essential to prevent metabolic crises and malignant ...
Volpe SG, Srinivasan A, Ayad S.
europepmc   +2 more sources

Pain on Injection of Rocuronium Bromide [PDF]

open access: yesAnesthesia & Analgesia, 1996
Contains fulltext : 22677___.PDF (Publisher’s version ) (Open Access)
Steegers, M.A.H., Robertson, E.N.
openaire   +6 more sources

Comparison of injection pain in pediatric population; original versus generic rocuronium

open access: yesSaudi Journal of Anaesthesia, 2020
Background: Rocuronium-induced injection pain causes withdrawal movements. These movements may cause accidental disruption of indwelling needles. Generic rocuronium contains low-acid concentration buffer solution compared with original rocuronium.
Fumio Watanabe   +2 more
doaj   +1 more source

Intravenous infusion of rocuronium bromide prolongs emergence from propofol anesthesia in rats.

open access: yesPLoS ONE, 2021
BackgroundNeuromuscular blocking agents induce muscle paralysis via the prevention of synaptic transmission at the neuromuscular junction and may have additional effects at other sites of action. With regard to potential effects of neuromuscular blocking
Kaoru Suzuki   +6 more
doaj   +1 more source

COMBINATION OF ROCURONIUM WITH PROPOFOL TO AID ENDOTRACHEAL INTUBATION IN EMERGNCY CESAREAN SECTION [PDF]

open access: yesBasrah Journal of Surgery, 2015
This study aimed to verify that rocuronium can be used as an alternative to succinylcholine for rapid sequence intubation in emergency cesarean section. A study conducted on 300 ladies in Al-Basrah Maternity and Childbirth Hospital between February 2013 ...
Edwar Z Khosho, Mohammad Radhi Al-Rekaby
doaj   +1 more source

Interaction of rocuronium with human liver cytochromes P450

open access: yesJournal of Pharmacological Sciences, 2015
Rocuronium is a neuromuscular blocking agent acting as a competitive antagonist of acetylcholine. Results of an inhibition of eight individual liver microsomal cytochromes P450 (CYP) are presented. As the patients are routinely premedicated with diazepam,
Eva Anzenbacherova   +6 more
doaj   +1 more source

SUGAMMADEX versus neostigmine after ROCURONIUM continuous infusion in patients undergoing liver transplantation

open access: yesBMC Anesthesiology, 2020
Background Rapid neuromuscular block reversal at the end of major abdominal surgery is recommended to avoid any postoperative residual block. To date, no study has evaluated sugammadex performance after rocuronium administration in patients undergoing ...
Cristian Deana   +4 more
semanticscholar   +1 more source

Rapid Sequence Induction With a Standard Intubation Dose of Rocuronium After Magnesium Pretreatment Compared With Succinylcholine: A Randomized Clinical Trial

open access: yesAnesthesia and Analgesia, 2020
BACKGROUND: Succinylcholine remains the muscle relaxant of choice for rapid sequence induction (RSI) but has many adverse effects. High-dose rocuronium bromide may be an alternative to succinylcholine for RSI but recovery times are nearly doubled ...
C. Czarnetzki   +7 more
semanticscholar   +1 more source

Rocuronium-sugammadex use for electroconvulsive therapy in a hemodialysis patient: a case report

open access: yesJA Clinical Reports, 2016
Background Recently, rocuronium with subsequent use of sugammadex was proposed for electroconvulsive therapy (ECT) as an alternative to succinylcholine.
Shigeaki Kurita   +5 more
doaj   +1 more source

Sugammadex for reversal of neuromuscular blockade: A retrospective analysis of clinical outcomes and cost-effectiveness in a single center [PDF]

open access: yes, 2016
OBJECTIVE: The aim of the study is to evaluate the clinical and economic impact of introducing a rocuronium-neostigmine-sugammadex strategy into a cisatracurium-neostigmine regimen for neuromuscular block (NMB) management.
BARATTO, FABIO   +3 more
core   +1 more source

Home - About - Disclaimer - Privacy